Intra-articular drug delivery: A fast growing approach

Recent Patents on Drug Delivery and Formulation

Volumn 2, Issue 3, 2008, Pages 231-237

  Aly, Maha Nasr Sayed ^a  

^a African Union Organization St Abbassia   (Egypt)

Author keywords

Hyaluronic acid; Hydrogels; Intraarticular; Osteoarthritis; Rheumatoid arthritis; Sustained release

Indexed keywords

ALBUMIN; APIGENIN; BIOMATERIAL; CHITOSAN; CHONDROITIN SULFATE; CORTICOSTEROID; DEXTRAN; DICLOFENAC; FLURBIPROFEN; GELATIN; GLUCURONIC ACID; GLYCOLIC ACID; GLYCYRRHIZIC ACID; HYALURONIC ACID; IBUPROFEN; INDOMETACIN; MACROGOL; METHOTREXATE; METHYLCELLULOSE; MICROSPHERE; N ACETYLGLUCOSAMINE; NANOPARTICLE; PACLITAXEL; PERFLUORODECALIN; PHOSPHATIDYLCHOLINE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; UNINDEXED DRUG; XYLOSE;

ANALGESIA; ARTHROPATHY; BIODEGRADABLE IMPLANT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STRUCTURE; DRUG TOLERABILITY; ENCAPSULATION; HUMAN; HYDROGEL; INCIDENCE; JOINT CAVITY; JOINT DEGENERATION; MACROMOLECULE; OSTEOARTHRITIS; PATENT; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC CIRCULATION; VISCOSITY;

EID: 58049209830     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221108786241651     Document Type: Review

References (74)

1. Paget J. Healing of injuries in various tissues. Lect Surg Pathol (Lond) 1853; 1: 262-270.
2. Kinner B, Spector M, Goldberg VM, Caplan AI. Cartilage current applications in orthopedic tissue engineering basic science and practice. New York, Marcel Dekker 2004; 201-236.
3. Buckwalter JA, Goldberg VM, Caplan AI. Articular cartilage overview in orthopedic tissue engineering basic science and practice. New York, Marcel Dekker 2004; 179-200.
4. Marcum, F.D., Seanor, J.W.: US20080003258 (2008).
5. Larsen C, Ostergaard J, Larsen SW, et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci 2008; doi:10.1002/jps.21346.
6. Abramson S. Drug delivery in degenerative joint disease Where we are and where to go? Adv Drug Deliv Rev 2006; 58: 125-127.
7. Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev 2006; 58: 226-242.
8. Wikipedia, the free encyclopedia. Hylauronic acid, http://en.wikipedia.org/wiki/Hyaluronicíd (accessed on April 28, 2008).
9. Thompson, J., Gosiewska, A., Niemiec, S., Dhanaraj, S.: WO03000191 (2003).
10. Niazi, S.: US2007142480 (2007).
11. Ghosh P, Guidolin D. Potential mechanism of action of intraarticular hylauronan therapy in osteoarthritis are the effects molecular weight dependent?. Semin Arthritis Rheum 2002; 32: 10-37.
12. Marcum, F.: US2006135470 (2006).
13. Francois, B.: WO07073835A3 (2007).
14. Drizen, A., Aviad, A.: US5079236 (1992).
15. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004; 86-A(3): 538-545.
16. Turajane T, Tanavaree A, Labpiboonpong V, Maungsiri S. Outcomes of intra-articular injection of sodium hylauronate for the treatment of osteoarthritis of the knee. J Med Assoc Thai 2007; 90: 1845-1852.
17. Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hylauronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthr Cartil 1995; 3: 269-273.
18. Mihara M, Higo S, Uchiyama Y, Tanabe K, Saito K. Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model. Osteoarthr Cartil 2007; 15: 543-549.
19. Moreland LW. Intra-articular hylauronan (hylauronic acid) and hylans for the treatment of osteoarthritis mechanisms of action. Arthritis Res Ther 2003; 5: 54-67.
20. Zhao, X., Alexander, C., Fraser, J.: US20077226972 (2007).
21. Barbucci R, Lamponi S, Borzacchiello A, et al. Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials 2002; 23: 4503-4513.
22. Callegaro, L., Renier, D.: WO07137674 (2007).
23. Venbrocks, R., Roth, A., Mueller, P., Moeller, S., Ozegowski, J., Peschel, G.: US2007054878 (2007).
24. Gobbo, S., Petrella, R.: WO07131546 (2007).
25. Brown, L.J., Cui, H., Wu, Z.: US2007141160 (2007).
26. Lyons, R.T., Robinson, M.R., Trogden, J.T., Whitcup, S.M.: US2008044476 (2008).
27. Tanaka, K.: US2004038936 (2004).
28. Argentieri, D.C., Carter, D., Brown, L.J., Geesin, J.C., Siekierka, J.J., Cui, H.: WO06039704 (2006).
29. Ikeya, H., Morikawa, T., Takahashi, K., Tamura, T., Okamachi, A., Ishizawa, T., Sato, H., Higuchi, Y.: US20070197465 (2007).
30. Elias, H.H.O.: MXPA01011542 (2003).
31. Shah, M.V., Weiner, A.L.: WO07008206 (2007).
32. Grinstaff, M.W., Wathier, M.: WO07136738A2 (2007).
33. Flannery, C.R., Corcoran, C.J., Freeman, B.A., Collins-Racie, L.A.: US2007191268 (2007).
34. Buckley, P.B., Green, J.H.A.: CA2326510 (1999).
35. Horisawa E, Kubota K, Tuboi I, et al. Size dependency of DLlactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res 2002; 19: 132- 139.
36. Fernandez-Carballido A, Herrero-Vanrell R, Molina-Martinez IT, Pastoriza P. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro. Int J Pharm 2004; 279: 33-41.
37. Lin SY, Chen KS, Teng HH, Li MJ. in vitro Degradation and dissolution behaviors of microspheres prepared by three low molecular weight polyesters. J Microencapsul 2000; 17: 557-586.
38. Thakker H, Sharma RK, Mishra AK, Chuttani K, Murthy RS. Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints. J Pharm Pharmacol 2004; 56: 1091-1099.
39. Thakker H, Sharma RK, Mishra AK, Chuttani K, Murthy RS. Celecoxib incorporated chitosan microspheres: in vitro and in vivo Evaluation. J Drug Target 2004; 12: 549-557.
40. Thakker H, Sharma RK, Mishra AK, Chuttani K, Murthy RR. Albumin micropsheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech 2005; 6: E65-E73.
41. Lu Y, Zhang G, Sun D, Zhong Y. Preparation and evaluation of biodegradable flubiprofen gelatin microspheres for intra-articular administration. J Microencapsul 2007; 24: 515-524.
42. Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy I, Hincal AA. in vitro and in vivo Evaluation of diclofenac sodium loaded albumin microspheres. J Microencapsul 2000; 17: 145-155.
43. Bozdag S, Calis S, Kas HS, Ercan MT, Peksoy I, Hincal AA. in vitro Evaluation and intra-articular administration of biodegradable microspheres containing naproxen sodium. J Microencapsul 2001; 18: 443-456.
44. Fernandez-Carballido A, Puebla P, Herrero-Vanrell R, Pastoriza P. Radiosterilization of indomethacin PLGA/PEG-derivative microspheres: Protective effects of low temperature during gammairradiation. Int J Pharm 2006; 313: 129-135.
45. Bragdon B, Bertone AL, Hardy J, Simmons EJ, Weisbrode SE. Use of an isolated joint model to detect early changes induced by intraarticular injection of paclitaxel-impregnated polymeric microspheres. J Invest Surg 2001; 14: 169-182.
46. Liggins RT, Cruz T, Min W, Liang L, Hunter WL, Burt HM. Intraarticular treatment of arthritis with microsphere formulations of paclitaxel: biocomptability and efficacy determinations in rabbits. Inflamm Res 2004; 53: 363-372.
47. Liang LS, Jackson J, Min W, Risovic V, Wasan KM, Burt HM. Methotrexate loaded poly(L-lactic acid) microspheres for intraarticular delivery of methotrexate to the joint. J Pharm Sci 2004; 93: 943-956.
48. Cai L, Okumu FW, Cleland JL, et al. A slow release formulation of insulin as a treatment for osteoarthritis. Osteoarthr Cartil 2002; 10: 692-706.
49. Holland TA, Mikos AG. Advances in drug delivery for articular cartilage. J Control Rel 2003; 86: 1-14.
50. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: Mechanisms of action. Arthritis Res Ther 2003; 5: 54-67.
51. Kim, M., Kim, S., Kwon, O.: US20077276251 (2007).
52. Suzuki, M., Ishigaki, K., Okada, M.: EP0911025A1 (1999).
53. Imasato, Y.U., Horisawa, E., Kawazoe, S., Hirota, T., Yamada, J., Kawashima, Y., Takeuchi, H., Yamamoto, H.: EP1010435A1 (2000).
54. Horisawa E, Hirota T, Kawazoe S, et al. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nano-spheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen induced arthritic rabbit. Pharm Res 2002; 19: 403-410.
55. Higaki M, Ishihara T, Izumo N, Takatsu M, Mizushima Y. Treatment of experimental arthritis with poly(D,L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis 2005; 64: 1132-1136.
56. Thakker H, Kumar SR, Murthy RS. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. Drugs R D 2007; 8: 275-285.
57. Foong WC, Green KL. Retention and distribution of liposomeentrapped [3H]methotrexate injected into normal or arthritic rabbit joints. J Pharm Pharmacol 1988; 40: 464-468.
58. Payne, N.I.: DE3912685 (1989).
59. Turker S, Erdogan S, Ozer AY, et al. Scintigraphic imaging of radiolabeled drug delivery systems in rabbits with arthritis. Int J Pharm 2005; 296: 34-43.
60. Petersen, J.: US20077186419 (2007).
61. Holland TA, Bodde EWH, Cuijpers VMJI, et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthr Cartil 2007; 15: 187-197.
62. Kusanagi, A., Tarrant, L.J.B., Schmidt, M.B.: US20077217294 (2007).
63. Betre H, Liu W, Zalutsky MR, Chilkoti A, Kraus VB, Setton LA. A thermally responsive biopolymer for intra-articular drug delivery. J Control Release 2006; 115: 175-182.
64. Setton, L.A., Chilkoti, A., Kraus, V.B., Betre, H., Dreher, M.R.: US20070009602 (2007).
65. Shamji MF, Betre H, Chen J, Kraus V, Chilkoti A, Setton LA. Development of a thermally responsive drug depot for intraarticular delivery of interleukin-1 receptor antagonist to attenuate inflammatory events in osteoarthritis. Osteoarthr Cartil 2007; 15: C226-C227.
66. Goldberg VM, Caplan AI. Principles of tissue engineering and regeneration of skeletal tissues. In Orthopedic tissue engineering basic science and practice. New York, Marcel Dekker 2004; 1-9.
67. Zhang, R., Peluso, D., Morris, E.: US20087323445 (2008).
68. Madry, H., Vunjak-Novakovic, G., Trippel, S.B., Freed, L.E., Langer, R.: US20077252982 (2007).
69. Adkisson, H.D.I.V., Seyedin, M.S.: WO06121612 (2006).
70. Radice, M., Pastorello, A., Pavesio, A., Callergaro, L.: US20077157080 (2007).
71. Nakao, K., Kitamura, H.: US20070197434 (2007).
72. Di Martino A, Sittinger M, Risbud MV. Chitosan A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005; 26: 5983-5990.
73. Hoemann CD, Sun J, Legare A, McKee MD, Buschmann MD. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell delivery vehicle. Osteoarthr Cartil 2005; 13: 318-329.
74. Zhang X, Yu C, XuShi, Zhang C, Tang T, Dai K. Direct chitosanmediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun 2006; 341: 202-208.